523
Views
0
CrossRef citations to date
0
Altmetric
Infectious Disease

A first-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending oral dose study to assess the safety, tolerability, and pharmacokinetics of BZF961 with and without ritonavir in healthy adult volunteers

, , , , , , & show all
Pages 66-74 | Received 15 Jun 2018, Accepted 09 Oct 2018, Published online: 24 Oct 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.